Galangin/β-Cyclodextrin Inclusion Complex as a Drug-Delivery System for Improved Solubility and Biocompatibility in Breast Cancer Treatment

The purpose of this study was to evaluate the potential of a newly modified cyclodextrin derivative, water-soluble β-cyclodextrin–epichlorohydrin (β-CD), as an effective drug carrier to enhance the poor solubility and bioavailability of galangin (GAL), a poorly water-soluble model drug. In this rega...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbas, Zainab S., Sulaiman, Ghassan M., Jabir, Majid S., Mohammed, Salman A. A., Khan, Riaz A., Mohammed, Hamdoon A., Al-Subaiyel, Amal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318178/
https://www.ncbi.nlm.nih.gov/pubmed/35889394
http://dx.doi.org/10.3390/molecules27144521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318178/
https://www.ncbi.nlm.nih.gov/pubmed/35889394
http://dx.doi.org/10.3390/molecules27144521

Ejemplares similares